Kalydeco 150 MG tablet 56S
Ended Awarded
- Contract number
- SPE2DB25FZP98
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,489
Award facts
- Contract value 100% obligated
- $18,489.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $18,489.00 to DMS Pharmaceutical Group Inc. for the supply of Kalydeco 150 mg tablets (56-count units). The award, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order from its Park Ridge facility. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities worldwide.
Kalydeco is a specialized cystic fibrosis treatment medication, and this delivery order represents a single transaction within DMS Pharmaceutical Group's extensive portfolio of federal pharmaceutical supply contracts. As a woman-owned small business pharmaceutical wholesaler, the company has established itself as a critical supplier in the federal pharmaceutical supply chain, consistently securing contracts with the Defense Logistics Agency for branded and generic prescription drugs, biologics, and medical consumables serving Department of Defense healthcare sites. The firm fixed-price structure and rapid completion timeline reflect the operational efficiency characteristic of delivery orders issued against established indefinite delivery contracts.
Quick answers
Who was awarded contract SPE2DB25FZP98?
SPE2DB25FZP98 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 28, 2025.
How much is contract SPE2DB25FZP98 worth?
The government has obligated $18,489 on SPE2DB25FZP98.
Is contract SPE2DB25FZP98 an order under another contract?
Yes. SPE2DB25FZP98 is a delivery order under SPE2DB22D9102, an indefinite delivery contract.
Was contract SPE2DB25FZP98 competed?
The extent of competition for SPE2DB25FZP98 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award